drugset / Trial / NCT01892254

Incretin Effect in PCOS Women

NCT01892254 ↗

Phase 4 Completed 20 enrolled University Hospital, Gentofte, Copenhagen
RandomizedCrossoverTriple-blindBasic science

Summary

This study investigates the incretin effect in women with polycystic ovary syndrome (PCOS) before and after removal of their insulin resistance by metformin. The investigators' hypothesis is that insulin resistant women with PCOS have a reduced incretin effect and elevated glucagon responses as measured by a 75-g oral glucose tolerance test and isoglycemic i.v. glucose infusion. The investigators hypothesise that both can be improved when their insulin resistance is removed.

Timeline

Start
2013-06
Primary completion
2017-11-23
Completion
2017-11-23

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule 1000 mg —